Suppr超能文献

相似文献

1
Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokines.
Cancer Sci. 2010 Feb;101(2):536-42. doi: 10.1111/j.1349-7006.2009.01411.x. Epub 2009 Oct 22.
2
NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.
Antiviral Res. 2019 Oct;170:104559. doi: 10.1016/j.antiviral.2019.104559. Epub 2019 Jul 15.
3
Targeting DNA Damage Response as a Strategy to Treat HPV Infections.
Int J Mol Sci. 2019 Nov 1;20(21):5455. doi: 10.3390/ijms20215455.
5
Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay.
PLoS Pathog. 2017 Feb 9;13(2):e1006168. doi: 10.1371/journal.ppat.1006168. eCollection 2017 Feb.
7
Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11138-E11147. doi: 10.1073/pnas.1801156115. Epub 2018 Nov 1.
8
HPV episome levels are potently decreased by pyrrole-imidazole polyamides.
Antiviral Res. 2011 Aug;91(2):177-86. doi: 10.1016/j.antiviral.2011.05.014. Epub 2011 Jun 2.
9
Development of protein-based antiviral drugs for human papillomaviruses.
Nucleic Acids Symp Ser (Oxf). 2007(51):427-8. doi: 10.1093/nass/nrm214.
10
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2025866118.

引用本文的文献

1
Three-dimensional cell culture models for investigating human viruses.
Virol Sin. 2016 Oct;31(5):363-379. doi: 10.1007/s12250-016-3889-z. Epub 2016 Oct 27.
2
Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1.
J Virol. 2015 May;89(9):5040-59. doi: 10.1128/JVI.00389-15. Epub 2015 Feb 25.
3
p38MAPK and MK2 pathways are important for the differentiation-dependent human papillomavirus life cycle.
J Virol. 2015 Feb;89(3):1919-24. doi: 10.1128/JVI.02712-14. Epub 2014 Nov 19.

本文引用的文献

1
Human papillomaviruses: a growing field.
Genes Dev. 2009 Jan 15;23(2):138-42. doi: 10.1101/gad.1765809.
2
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.
Genes Dev. 2009 Jan 15;23(2):181-94. doi: 10.1101/gad.1735109. Epub 2009 Jan 8.
3
Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1.
EMBO J. 2008 Dec 17;27(24):3311-21. doi: 10.1038/emboj.2008.241. Epub 2008 Nov 13.
4
Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins.
J Virol. 2008 Sep;82(17):8820-7. doi: 10.1128/JVI.02363-07. Epub 2008 Jun 25.
6
HPV and cervical cancer in the 2007 report.
Vaccine. 2007 Nov 1;25 Suppl 3:C1-230. doi: 10.1016/S0264-410X(07)01183-8.
7
Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification.
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19541-6. doi: 10.1073/pnas.0707947104. Epub 2007 Nov 28.
8
HPV: from infection to cancer.
Biochem Soc Trans. 2007 Dec;35(Pt 6):1456-60. doi: 10.1042/BST0351456.
9
Recognition of viruses by innate immunity.
Immunol Rev. 2007 Dec;220:214-24. doi: 10.1111/j.1600-065X.2007.00562.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验